Regenerative Therapy Makes Headway in HF ... in the Right Patients

(MedPage Today) -- Cell-patch therapy was safe and feasible for nonischemic dilated cardiomyopathy (NIDCM), and Japanese researchers reported being a step closer to identifying which patients are most likely to benefit.
Autologous skeletal cell...